Serum C‐Reactive Protein as a Potential Indicator for Screening Fecal Calprotectin in Patients With Moderate‐to‐Severe Hidradenitis Suppurativa: A Cross‐Sectional Cohort Study
International Journal of Dermatology · 2025
DOI: 10.1111/ijd.17868 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Neslihan Demirel Öğüt und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Faculty of Medicine, Uşak University, Uşak, Turkey. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, C-Reactive Protein, Leukocyte L1 Antigen Complex, Feces. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Uşak University Scientific Research Projects Coordinatorship.
Abstract (Originalsprache)
Background
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder frequently associated with immune‐mediated comorbidities, including inflammatory bowel disease (IBD). Given the potential risk of IBD, particularly before initiating therapies such as interleukin (IL)‐17 inhibitors, screening through a fecal calprotectin (FC) test may be warranted. While FC is a reliable, non‐invasive biomarker for ruling out IBD, its cost and limited availability in dermatology settings present challenges. Therefore, this study aims to investigate the potential association between FC and serum C‐reactive protein (CRP) levels in patients with moderate‐to‐severe HS, which may provide a more accessible screening approach.
Method
This cross‐sectional cohort study was conducted at the Department of Dermatology and Venereology of Uşak University between April 2, 2024, and December 31, 2024, including 18–65‐year‐old patients with moderate‐to‐severe HS. Serum CRP and FC levels were analyzed using an enzyme‐linked immunosorbent assay (ELISA).
Results
Stool samples from 61 patients with moderate‐to‐severe HS were included. The median FC and serum CRP levels were 28.2 μg/g and 5.3 mg/L, respectively, with a significant correlation between them (rho = 0.289, p = 0.026). While FC levels did not significantly differ between moderate and severe HS, CRP levels were significantly higher in patients with severe disease ( p = 0.009). Receiver operating characteristic (ROC) analysis identified a CRP cut‐off of 5.35 mg/L for predicting FC ≥ 50 μg/g (AUC = 0.660, p = 0.045), with 70% sensitivity and 61.5% specificity.
Conclusion
Patients with moderate‐to‐severe HS and serum CRP levels above 5.35 mg/L may benefit from FC screening, and those with FC levels exceeding 50 μg/g may be considered for further endoscopic evaluation to assess IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Faculty of Medicine, Uşak University, Uşak, Turkey.
- Department of Medical Biology, Faculty of Medicine, Uşak University, Uşak, Turkey.
ORCID-Profile: Neslihan Demirel Öğüt, Rahşan Ilıkçı Sağkan, Ece Gökyayla, Simge Ünal, Sema Koç Yıldırım, Ece Erbağcı, Ayris Öztürk
Förderung
- Uşak University Scientific Research Projects Coordinatorship
Zitieren
APA
Demirel Öğüt, N., Ilıkçı Sağkan, R., Arıcı, R., Gökyayla, E., Ünal, S., Koç Yıldırım, S., Erbağcı, E., & Öztürk, A. (2025). Serum C‐Reactive Protein as a Potential Indicator for Screening Fecal Calprotectin in Patients With Moderate‐to‐Severe Hidradenitis Suppurativa: A Cross‐Sectional Cohort Study. International Journal of Dermatology. https://doi.org/10.1111/ijd.17868
Vancouver
Demirel Öğüt N, Ilıkçı Sağkan R, Arıcı R, Gökyayla E, Ünal S, Koç Yıldırım S, et al. Serum C‐Reactive Protein as a Potential Indicator for Screening Fecal Calprotectin in Patients With Moderate‐to‐Severe Hidradenitis Suppurativa: A Cross‐Sectional Cohort Study. International Journal of Dermatology. 2025. doi:10.1111/ijd.17868
BibTeX
@article{Demirelt2025,
author = {Demirel Öğüt, Neslihan and Ilıkçı Sağkan, Rahşan and Arıcı, Rabia and Gökyayla, Ece and Ünal, Simge and Koç Yıldırım, Sema and Erbağcı, Ece and Öztürk, Ayris},
title = {Serum C‐Reactive Protein as a Potential Indicator for Screening Fecal Calprotectin in Patients With Moderate‐to‐Severe Hidradenitis Suppurativa: A Cross‐Sectional Cohort Study},
journal = {International Journal of Dermatology},
year = {2025},
doi = {10.1111/ijd.17868}
}
EUVIMED